This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
CHANGE IN RATINGSAMC Networks(AMCX) rated new Overweight at JP Morgan. $43 price target. Pullback has created an attractive buying opportunity in the growing company.
Amazon.com(AMZN - Get Report) rated new Outperform at Morgan Keegan. $210 price target. Company can continue to gain market share in North America.
Acme Packet(APKT) rated new Neutral at JP Morgan. $29 price target. Inflection point in growth may still be several quarters away.
Bill Barrett(BBG) downgraded to hold at TheStreet Ratings.
Biglari Holdings(BH) downgraded to hold at TheStreet Ratings.
Broadcom(BRCM) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call, as earnings should rebound in 2012.
Boston Scientific(BSX - Get Report) downgraded at Goldman to Sell, Goldman Sachs said. Consensus estimates appear too high.
BorgWarner(BWA) downgraded at UBS from Buy to Neutral, UBS said. $68 price target. Europe headwinds remain despite german OEM exposure.
Deckers(DECK) downgraded at Sterne Agee from Buy to Underperform, Sterne Agee said. Estimates also cut, following disappointing channel checks for UGG. $72 price target.
First Solar(FSLR - Get Report) downgraded at Baird from Outperform to Neutral, Robert Baird said. $35 price target. Company slashed it guidance and the business is in a transition period.
Forest Oil(FST) rated new Hold at Keybanc. Company still has to show that it can generate growth in newer shale areas.
Gulfport Energy(GPOR) rated new Outperform at Credit Suisse. $41 price target. Utica shale should continue to drive growth.
Hospira(HSP) rated new Sell at UBS. $25 price target. Recovery from manufacturing issues could be slow.
ITC(ITC) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. Company can deliver above-average growth in the coming quarters. $79 price target.
Kior(KIOR) upgraded at Baird from Underperform to Neutral, Robert Baird said. Valuation call, based on a $10 price target.
Laboratory Corp.(LH) downgraded at Goldman to Sell, Goldman Sachs said. Industry is facing flat volumes and rising costs.
Lam Research(LRCX) upgraded at Needham from Hold to Buy, Needham said. $46 price target. NVLS purchase will improve scale and customer leverage.
PerkinElmer(PKI) upgraded at Goldman to Buy, Goldman Sachs said. Sentiment appears to have bottomed out for the group.